Submitted by Anonymous (not verified) on 20 January 2026 - 15:56
Human medicines European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene), pomalidomide, Date of authorisation: 05/08/2013, Revision: 26, Status: Authorised
Source: